Stock analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock.
Ayala Pharmaceuticals Price Performance
Shares of ADXS opened at $0.10 on Monday. The company has a market capitalization of $4.31 million, a P/E ratio of -0.01 and a beta of 1.51. Ayala Pharmaceuticals has a one year low of $0.00 and a one year high of $1.49. The business’s 50 day simple moving average is $0.05 and its 200-day simple moving average is $0.30.
Ayala Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ayala Pharmaceuticals
- Short Selling: How to Short a Stock
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Why Invest in 5G? How to Invest in 5G Stocks
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What is the Nikkei 225 index?
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.